ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PROF vs OSUR // EV/EBITDA & P/E VALUATION

Profound Medical Corp. (NASDAQ) VS. OraSure Technologies Inc. (NASDAQ) • 15-METRIC TALLY: PROF 6 — OSUR 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROF VS. OSUR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PROF OSUR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.80% 41.90% +28.90 PROF /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -17.93% -18.91% +0.98 PROF /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -59.80% -0.20 OSUR /net-margins <GO>
Revenue Growth (YoY) 65.30% -38.10% +103.40 PROF /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.97 2.47 +3.50 PROF /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 PROF /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.4 51.3 +5.10 PROF /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $240.0M $271.7M -$31.7M OSUR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PROF REV OSUR REV PROF GROSS % OSUR GROSS % PROF FCF OSUR FCF
FY 2025 $16.1M $115.0M 70.8% 41.9% -$38.4M -$53.2M
FY 2024 $9.7M $185.8M 72.2% 42.7% -$23.5M $23.6M
FY 2023 $5.9M $405.5M — — -$22.6M $141.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROF // BETA —
OSUR // BETA —